The increase of T-LGL incidence may be attributed to greater diagnostic familiarity of clinicians through laboratory testing, including T-cell receptor gene rearrangement [9] and next generation sequencing to detect STAT3 mutations, which are often detected in T-LGL [10]. Here, STAT3 is linked to T-cell large granular lymphocyte leukemia.